AgeX Therapeutics Inc (STU:0X40)
€ 13.7163 0 (0%) Market Cap: 25.61 Mil Enterprise Value: 29.32 Mil PE Ratio: 0 PB Ratio: 2.19 GF Score: 36/100

AgeX Therapeutics Inc Longevity Forum 2018 Transcript

Jan 10, 2020 / NTS GMT
Unidentified Participant

Now we are lucky enough to have Dr. Mike West, CEO & Founder of AgeX, who has more patents to his name than anyone in this field, and who is a specialist in stem cells, which is the second leg of the small molecule in this pro-longevity science business. So over to you, Mike.

Mike West
AgeX Therapeutics, Inc. - CEO & Founder

Thank you. It's a pleasure to be here by the way. Early on Jim mentioned the engineering of ourselves, engineering not just themselves in the dish, but of ourselves and our loved ones. And that's of course, the realm of biotechnology. And so what I'm going to do is give you a peek inside of the windows of a biotech company, we call AgeX. And in doing so, I'll be making certain forward-looking statements. We're about to be a public company ourselves. And so I'll also disclose option holder in the company.

So what is AgeX? So we're a company focused on the development of young cell-based therapies for the treatment of human aging. And again, I'll point to this curve, but for a different reason. So this is not the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot